Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Scientists have synthesized this fragment in the lab, rendering it a synthetic peptide
Quick answer No, GHK-Cu is not an FDA-approved drug for any human therapeutic indication, and neither are BPC-157 or TB-500
Structurally related to angiotensin IV analogs, it is studied in controlled experimental settings for its interaction with hepatocyte growth factor (HGF)/c-Met signaling pathways and its role in cellular communication and neurobiological research models
Any reconstitution and administration of this compound outside a regulated clinical trial or supervised medical setting is unsafe and falls outside the bounds of regulated UK healthcare
US$ 24.86
US$ 29.25
US$ 28.75
US$ 25.55
US$ 27.89
US$ 25.98
US$ 20.27
